Unexplained infertility can persist even when scans, hormone tests, and other routine checks show normal results. Research now looks more closely at changes inside the lining of the uterus that standard tests are unable to detect. Tissue-based evaluation can identify inflammatory activity and functional changes in the endometrium that influence implantation outcomes. Here is some information on the latest research on unexplained infertility:
Identifying Hidden Uterine Inflammation
Endometrial inflammation is identified as a contributor to unexplained infertility and pregnancy loss when standard evaluations appear normal. Tissue analysis measures inflammatory activity directly through biomarker expression within the uterine lining. This method may use molecular signals rather than symptoms or imaging to assess endometrial function. Inflammation in the uterine lining often shows association with endometriosis; this includes cases without symptoms. Changes in the endometrium can reduce its ability to support implantation even without visible lesions.
Endometriosis may be the source of inflammation, and it is sometimes identified by testing for CD138, which is a marker of chronic endometritis. Clinical interpretation distinguishes between the presence and absence of inflammatory markers. Positive findings indicate inflammation associated with endometrial dysfunction, while negative findings reduce the likelihood of inflammation-related pathology.
Understanding BCL6 Biomarker Role
BCL6 is a regulatory protein that assists in maintaining normal uterine and placental functionality during reproduction. Clinicians evaluate whether this protein is present at abnormal levels in the endometrium and whether it is associated with changes linked to fertility problems. BCL6 interacts with SIRT1 in endometrial cells and alters the pathways of progesterone signaling; this affects the uterine lining’s response during the implantation phase.
Hormone levels in the bloodstream may remain within expected ranges, yet the endometrial response becomes altered at the cellular level. A reduced response of the endometrium to progesterone is sometimes associated with this BCL6-related signaling disruption. The lining of the uterus does not progress through the normal preparation required for implantation. Instead, changes occur in gene activity and cellular behavior that affect receptivity during the implantation window.
Detecting Silent Endometriosis
Endometriosis may be present without evident symptoms, which makes recognition difficult during routine fertility assessments, including cases of unexplained infertility. Clinicians use imaging and surgical evaluation to assess endometriosis. Imaging might not detect early or mild disease in the pelvis. Surgical evaluation provides direct visualization of endometriosis, but its use varies across fertility assessments due to its invasive nature. Endometrial biopsy analysis evaluates inflammatory activity in the uterine lining; this method measures BCL6 expression. Instead of identifying lesions, the test evaluates molecular changes within endometrial tissue.
Examining Progesterone Resistance
Progesterone resistance describes a reduced response of the uterine lining to this hormone despite normal levels. This condition affects how the endometrium prepares for implantation during the luteal phase. Progesterone regulates changes in the endometrium required for implantation; when the response is altered, the lining may not complete the normal sequence of preparation needed for embryo attachment. The endometrium shows changes in gene activity that affect how it responds to progesterone; these changes influence the ability of the tissue to support implantation and early development. This pattern can appear in implantation failure, recurrent pregnancy loss, unexplained infertility, and repeated unsuccessful IVF cycles after embryo transfer.
Using Endometrial Biopsy
An endometrial biopsy involves obtaining a tissue sample from the uterine lining for evaluation. Clinicians carry out the procedure during the luteal phase to capture progesterone-related changes in the endometrium. Physicians collect the tissue sample using a thin catheter in an outpatient setting, and the process does not require surgery or limit return to normal activity after collection.
Biopsies provide access to endometrial information that imaging may not detect. Laboratory analysis evaluates molecular and histologic features of the endometrial tissue; it includes assessment of BCL6 expression, histologic examination, and endometrial dating to confirm cycle stage. When needed, CD138 staining identifies plasma cells to assess chronic endometritis within the same sample.
Work With Unexplained Infertility Specialists
Advances in endometrial diagnostics have introduced a more detailed view of factors influencing unexplained infertility and failed IVF cycles. Molecular analysis of the uterine lining reveals conditions that standard evaluations may not identify, and these insights support a more precise assessment of implantation-related challenges. Contact a fertility doctor today to evaluate unexplained infertility and discuss appropriate diagnostic and testing options.
